Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tack

Showing results (631-640 of 727) with videos related to

Pageof 73
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 7, 2020
Evaluation of cyclooxygenase oxylipins as potential biomarker for obesity-associated adipose tissue inflammation and type 2 diabetes using targeted multiple reaction monitoring mass spectrometryRoel Tans, Rieke Bande, Arno van Rooij, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetesCees J Tack, Vladimir Christov, Bastiaan E de Galan, et al.
Cardiovascular Diabetology|February 8, 2024
The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episodeClementine E M Verhulst, Julia I P van Heck, Therese W Fabricius, et al.
Diabetes, Obesity & Metabolism|July 24, 2023
Hypoglycaemia induces a sustained pro-inflammatory response in people with type 1 diabetes and healthy controlsClementine E M Verhulst, Julia I P van Heck, Therese W Fabricius, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2008
Clinical trial design in adult reflux disease: a methodological workshopJ Dent, P J Kahrilas, N Vakil, et al.
Diabetes|July 18, 2022
Sustained Proinflammatory Effects of Hypoglycemia in People With Type 2 Diabetes and in People Without DiabetesClementine E M Verhulst, Julia I P van Heck, Therese W Fabricius, et al.
BMC Gastroenterology|November 14, 2012
Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort studyGreetje J Tack, Roy L J van Wanrooij, B Mary E Von Blomberg, et al.
Diabetes Care|July 26, 2012
Metabolic effects of high altitude trekking in patients with type 2 diabetesPieter de Mol, Marion J Fokkert, Suzanna T de Vries, et al.
Alimentary Pharmacology & Therapeutics|February 20, 2015
Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapyN J Shaheen, J Adler, S Dedrie, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2012
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersJ Tack, M Camilleri, L Chang, et al.
Pageof 73

Showing results (631-640 of 727) with videos related to

Sort By:
Pageof 73
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 7, 2020
Evaluation of cyclooxygenase oxylipins as potential biomarker for obesity-associated adipose tissue inflammation and type 2 diabetes using targeted multiple reaction monitoring mass spectrometryRoel Tans, Rieke Bande, Arno van Rooij, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetesCees J Tack, Vladimir Christov, Bastiaan E de Galan, et al.
Cardiovascular Diabetology|February 8, 2024
The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episodeClementine E M Verhulst, Julia I P van Heck, Therese W Fabricius, et al.
Diabetes, Obesity & Metabolism|July 24, 2023
Hypoglycaemia induces a sustained pro-inflammatory response in people with type 1 diabetes and healthy controlsClementine E M Verhulst, Julia I P van Heck, Therese W Fabricius, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2008
Clinical trial design in adult reflux disease: a methodological workshopJ Dent, P J Kahrilas, N Vakil, et al.
Diabetes|July 18, 2022
Sustained Proinflammatory Effects of Hypoglycemia in People With Type 2 Diabetes and in People Without DiabetesClementine E M Verhulst, Julia I P van Heck, Therese W Fabricius, et al.
BMC Gastroenterology|November 14, 2012
Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort studyGreetje J Tack, Roy L J van Wanrooij, B Mary E Von Blomberg, et al.
Diabetes Care|July 26, 2012
Metabolic effects of high altitude trekking in patients with type 2 diabetesPieter de Mol, Marion J Fokkert, Suzanna T de Vries, et al.
Alimentary Pharmacology & Therapeutics|February 20, 2015
Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapyN J Shaheen, J Adler, S Dedrie, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2012
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersJ Tack, M Camilleri, L Chang, et al.
Pageof 73